FDA Adverse Event Malfunction Summary report: N

CELL-DYN HEMOGLOBIN/NOC LYSE

MDR report key: 2077058 · Received May 4, 2011

Report

Report Number
2919069-2011-00191
Event Type
Malfunction
Date Received
May 4, 2011
Date of Event
April 11, 2011
Report Date
April 11, 2011
Manufacturer
ABBOTT DIAGNOSTICS DIVISION
Product Code
GKZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE INITIAL REPORT WAS SUBMITTED UNDER CATALOG NUMBER 3H80-02, (B)(4) MANUFACTURING SITE. IT WAS DETERMINED THAT THE INVESTIGATION SHOULD BE PERFORMED ON CATALOG NUMBER 3H62-01, (B)(4) MANUFACTURING SITE. THE RISK MANAGEMENT FILE FOR THE CELLDYN 3700 ANALYZER INDICATES THAT THE USER MAY BE EXPOSED TO CHEMICAL HAZARDS WHEN COMING INTO CONTACT WITH REAGENTS DURING INSTRUMENT MAINTENANCE. CONTROLS IN PLACE TO REDUCE THE RISK ARE PERSONAL PROTECTIVE EQUIPMENT, HANDLING INSTRUCTIONS, HAZARD CLASSIFICATIONS, MATERIAL SAFETY DATA SHEETS, AND INSTRUCTIONS IN THE MANUAL FOR HANDLING AND MAINTENANCE OF THE INSTRUMENT. CUSTOMER COMPLAINT DATA WAS REVIEWED AND NO ADVERSE TRENDS WERE IDENTIFIED. THE CELLDYN 3700 SYSTEM OPERATORS MANUAL WAS REVIEWED AND WAS FOUND TO ADEQUATELY ADDRESS THE ISSUE. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT DEFICIENCY.

Additional Manufacturer Narrative · 1

(B)(4). AN INVESTIGATION IS IN PROCESS. A FOLLOWUP REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.

Description of Event or Problem · 1

THE CUSTOMER STATED THAT THE LYSE REAGENT ON THE CD3700SL ANALYZER WAS EMPTY. WHEN SHE OPENED THE CAP OF THE LYSE REAGENT PART OF THE REAGENT THAT WAS LEFT IN THE BOTTLE SPRAYED OUT WITH PRESSURE IN HER EYE AND ON HER FACE. THE TECHNICIAN WASHED THE AREA WITH A LOT OF WATER. THERE WAS NO IRRITATION OR INJURY AND NO TREATMENT WAS NECESSARY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CELL-DYN HEMOGLOBIN/NOC LYSE LYSE REAGENT FOR HEMOGLOBIN ON THE CELL-DYN GKZ ABBOTT DIAGNOSTICS DIVISION

Patients

Seq Age Sex Outcome Treatment
1 CD3700 SL LN 2H31-01 SN (B)(4)| CD3700 SL LN 2H31-01 SN (B)(4)